George Ralis

George Ralis serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements definition and solicitation development to contract award and administration. He plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) and advancing mission-critical research initiatives through transparent, competitive procurement processes. His portfolio primarily encompasses scientific and technical services, with a strong emphasis on research and development contracts that support innovation in life sciences and biotechnology. Ralis works closely with program offices to translate technical needs into enforceable contract vehicles, ensuring alignment with agency objectives and regulatory standards. While specific contractor names are not available, Ralis consistently engages a diverse pool of vendors, including both large prime contractors and small businesses with specialized scientific capabilities. His procurement approach emphasizes open competition and merit-based selection, fostering partnerships with firms possessing expertise in laboratory research, clinical trial support, and analytical instrumentation. He maintains a collaborative relationship with industry stakeholders, often participating in pre-solicitation outreach to clarify technical requirements and promote fair access to opportunities. Ralis demonstrates a strong commitment to small business participation, with 31.3% of his awards designated as Total Small Business Set-Asides under FAR 19.5, reflecting a deliberate strategy to expand market access for small firms. His set-aside preferences prioritize broad small business eligibility over narrower socioeconomic categories, indicating a focus on capability and capacity rather than specific certifications. This pattern supports a robust ecosystem of small, innovative firms engaged in federal R&D. His primary procurement focus lies in NAICS 541714 (Biotechnology R&D) and 541712 (Physical, Engineering, and Life Sciences R&D), reflecting deep expertise in procuring services related to drug discovery, molecular analysis, clinical research, and laboratory testing. He routinely manages contracts for scientific consulting, experimental design, data analytics, and instrumentation development, demonstrating specialized knowledge in the technical domains of biomedical and life sciences research.